Loading asset research
Fennec Pharmaceuticals Inc. Common Stock
FENCNasdaq · USD · StocksQuote as of · Exchange session not verified$10.96
-3.01%
Today
FENC
Loading 1D prices…
Market cap
$384.3M
Volume
249.9K
52w high
$13.2552w low
$5.65Company profile
Fennec Pharmaceuticals Inc. Common Stock
Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cisplatin-induced ototoxicity pediatric patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. Fennec Pharmaceuticals Inc. has collaboration with Tampa General Hospital Foundation, Inc. for evaluation of clinical utility of sodium thiosulfate injection in reducing the risk of ototoxicity in adolescent, young adult, and adult cancer patients receiving cisplatin-based treatment; and Norgine Pharma UK Limited. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.
Sector
Health Care
Industry
Biological Products, (No Diagnostic Substances)
Exchange
Nasdaq
Display currency
USD
Location
Research Triangle Park, NC, United States
Employees
35
Fiscal year end
1231
CIK
1211583
Session & valuation
Open$11.30
Previous close$11.30
Day high$11.51
Day low$10.85
30-day avg. volume252.4K
Outstanding shares35.1M
Diluted EPS-$0.34
Latest annual period
P/E (trailing)-32.24
P/E (forward)11.56
Price / book9.05
Beta1.10
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2836
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| CMPXCompass Therapeutics Inc. Common Stock | $360.2M | $0.00 | — | -$0.42 | -2.68% | Buy |
| PALIPalisade Bio Inc. Common Stock | $359M | $0.00 | — | -$0.30 | +2.24% | Buy |
| EDITEditas Medicine Inc. Common Stock | $414.7M | $40.5M | -395.01% | -$1.80 | +2.64% | Hold |
| IPSCCentury Therapeutics Inc. Common Stock | $351.3M | $109.2M | -8.78% | -$0.14 | 0.00% | Buy |
| LXEOLexeo Therapeutics Inc. Common Stock | $348.7M | $0.00 | — | -$1.86 | -2.52% | Buy |